Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 144
Filter
Add more filters

Publication year range
1.
Opt Lett ; 40(11): 2525-8, 2015 Jun 01.
Article in English | MEDLINE | ID: mdl-26030548

ABSTRACT

We performed femtosecond laser-induced damage threshold (fs LIDT) measurements with substantially different repetition rate Ti:sapphire laser systems: a 1 kHz regenerative amplifier and a 4.3 MHz long-cavity oscillator. All other pulse parameters are kept the same. Comparative measurements of a dielectric high reflector, a chirped mirror, and metallic mirrors show at least a factor of 2.7 lower fs LIDT at megahertz repetition rates. We attribute this to thermally assisted damage mechanisms supported by complex heat transfer simulations.

2.
Sci Rep ; 14(1): 18288, 2024 Aug 07.
Article in English | MEDLINE | ID: mdl-39112559

ABSTRACT

In this brief report, we present laser induced breakdown spectroscopy (LIBS) evidence of deuterium (D) production in a 3:1 urethane dimethacrylate (UDMA) and triethylene glycol dimethacrylate (TEGDMA) polymer doped with resonant gold nanorods, induced by intense, 40 fs laser pulses. The in situ recorded LIBS spectra revealed that the D/(2D + H) increased to 4-8% in the polymer samples in selected events. The extent of transmutation was found to linearly increase with the laser pulse energy (intensity) between 2 and 25 mJ (up to 3 × 1017W/cm2). The observed effect is attributed only to the field enhancing effects due to excited localized surface plasmons on the gold nanoparticles.

3.
Infection ; 40(4): 441-3, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22002736

ABSTRACT

Dengue virus (DENV) is an arthropod-borne virus (family Flaviviridae) causing dengue fever or dengue hemorrhagic fever. Here, we report the first fatal DENV infection imported into Germany. A female traveler was hospitalized with fever and abdominal pain after returning from Ecuador. Due to a suspected acute acalculous cholecystitis, cholecystectomy was performed. After cholecystectomy, severe spontaneous bleeding from the abdominal wound occurred and the patient died. Postmortem analysis of transudate and tissue demonstrated a DENV secondary infection of the patient and a gallbladder wall thickening (GBWT) due to an extensive edema.


Subject(s)
Severe Dengue/mortality , Travel , Adult , Fatal Outcome , Female , Germany , Humans
4.
Clin Infect Dis ; 50(8): 1112-9, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20205588

ABSTRACT

BACKGROUND: This article describes multiple transmissions of rabies via transplanted solid organ from a single infected donor. The empirical Milwaukee treatment regimen was used in the recipients. METHODS: Symptomatic patients were treated by deep sedation (ketamine, midazolam, and phenobarbital), ribavirin, interferon, and active and passive vaccination. Viral loads and antibodies were continuously monitored. RESULTS: Recipients of both cornea and liver transplants developed no symptoms. The recipient of the liver transplant had been vaccinated approximately 20 years before transplantation. Two recipients of kidney and lung transplants developed rabies and died within days of symptomatic disease. Another kidney recipient was treated 7 weeks before he died. The cerebrospinal fluid viral load remained at constant low levels (<10,000 copies/mL) for approximately 5 weeks; it increased suddenly by almost 5 orders of magnitude thereafter. After death, no virus was found in peripheral compartments (nerve tissue, heart, liver, or the small intestine) in this patient, in contrast to in patients in the same cohort who died early. CONCLUSIONS: Our report includes, to our knowledge, the longest documented treatment course of symptomatic rabies and the first time that the virus concentration was measured over time and in different body compartments. The postmortem virus concentration in the periphery was low, but there was no evidence of a reduction of virus in the brain.


Subject(s)
Antibodies, Viral/administration & dosage , Antiviral Agents/therapeutic use , Hypnotics and Sedatives/therapeutic use , Organ Transplantation/adverse effects , Rabies Vaccines/administration & dosage , Rabies virus/isolation & purification , Rabies/drug therapy , Adult , Aged , Antibodies, Viral/blood , Female , Humans , Male , Middle Aged , Rabies Vaccines/immunology , Treatment Outcome , Viral Load
5.
J Exp Med ; 187(6): 949-59, 1998 Mar 16.
Article in English | MEDLINE | ID: mdl-9500797

ABSTRACT

The efficacy of triple drug therapy for HIV-1 infection encourages its early use to prevent damage to the immune system. We monitored the effects of such therapy on 12 patients with 14-75-mo histories of minimal disease, i.e., CD4+ counts constantly >500/microl and little or no lymph node enlargement. In this way, we could first determine the extent of viral replication and immunoarchitectural changes in unenlarged nodes early in disease, and second follow the response to triple therapy in plasma and lymphoid tissue in tandem. As is known for lymph nodes with more advanced disease, the germinal centers showed productively infected T cells, i.e., CD4+CD1a-CD68- cells labeling intensely for HIV-1 RNA after in situ hybridization. The unenlarged nodes also showed extensive HIV-1 RNA retention on a well-preserved, follicular dendritic cell (FDC) network, and the follicles were abnormal. There were numerous CD8+ cells, many expressing TIA-1 granule antigen. Also, in contrast to normal follicles, CD4+ T cell proliferation was active, with marked increases in the number of cycling, Ki-67+CD4+CD45R0+ cells. After 28 d and 3 mo of therapy, productively infected T cells decreased dramatically and often were not apparent. The labeling of the FDC network for viral RNA also decreased, but not for gag protein. We conclude that HIV-1 replicates and accumulates in lymphoid organs before damage of the immune system, that at this stage of disease de novo production of T cells occurs in the lymphoid tissue, and that the infection is sensitive to triple drug therapy in both plasma and lymph nodes.


Subject(s)
Acquired Immunodeficiency Syndrome/virology , Anti-HIV Agents/therapeutic use , CD4 Lymphocyte Count , HIV-1 , Lymph Nodes/virology , Lymphocyte Activation , Virus Replication , Acquired Immunodeficiency Syndrome/drug therapy , Acquired Immunodeficiency Syndrome/immunology , Adult , Female , Humans , Lymph Nodes/pathology , Male , Middle Aged , RNA, Viral/analysis
6.
J Exp Med ; 188(6): 1159-71, 1998 Sep 21.
Article in English | MEDLINE | ID: mdl-9743534

ABSTRACT

CD4+ T lymphocyte depletion in human immunodeficiency virus type 1 (HIV-1)-infected humans underlies the development of acquired immune deficiency syndrome. Using a model in which rhesus macaques were infected with chimeric simian-human immunodeficiency viruses (SHIVs), we show that both the level of viremia and the structure of the HIV-1 envelope glycoprotein ectodomains individually contributed to the efficiency with which CD4(+) T lymphocytes were depleted. The envelope glycoproteins of recombinant SHIVs that efficiently caused loss of CD4(+) T lymphocytes exhibited increased chemokine receptor binding and membrane-fusing capacity compared with those of less pathogenic viruses. These studies identify the HIV-1 envelope glycoprotein ectodomains as determinants of CD4(+) T lymphocyte loss in vivo and provide a foundation for studying pathogenic mechanisms.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , HIV-1/immunology , Lymphocyte Depletion , Simian Acquired Immunodeficiency Syndrome/immunology , Viral Envelope Proteins/physiology , Animals , Antiviral Agents/immunology , CD4-Positive T-Lymphocytes/virology , Chimera/immunology , Giant Cells/virology , HIV-1/genetics , HIV-1/pathogenicity , Humans , Lymph Nodes/virology , Lymphocyte Count , Macaca mulatta , Neutralization Tests , Protein Structure, Tertiary , Simian Acquired Immunodeficiency Syndrome/genetics , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/genetics , Simian Immunodeficiency Virus/immunology , Simian Immunodeficiency Virus/pathogenicity , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics , Virus Replication/genetics , Virus Replication/immunology
7.
Opt Express ; 18(23): 24206-12, 2010 Nov 08.
Article in English | MEDLINE | ID: mdl-21164766

ABSTRACT

We present experimental evidence of the generation of few-cycle propagating surface plasmon polariton wavepackets. These ultrashort plasmonic pulses comprised of only 2-3 field oscillations were characterized by an autocorrelation measurement based on electron photoemission. By exploiting plasmonic field enhancement, we achieved plasmon-induced tunnelling emission from the metal surface at low laser intensity, opening perspectives for strong-field experiments with low pulse energies. All-optical electron acceleration up to keV kinetic energy is also demonstrated in these surface-confined, few-cycle fields with only 1.35×10(12) W/cm2 focused laser intensity. The experimental results are found to be in excellent agreement with the model.

8.
Exp Eye Res ; 91(1): 76-84, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20412792

ABSTRACT

Wide-line (1)H NMR signal intensity, spin-lattice and spin-spin relaxation rates and differential scanning calorimetry (DSC) measurements were done on avian (chicken and turkey) crystalline lenses between -70 degrees C and +45 degrees C to provide quantitative measures of protein hydration characteristic of the protein-water interfacial region. These measures are of paramount importance in understanding both the physiology of crystalline lens and its transitions to the cataractous pathological state characterized by the formation of opaque protein aggregates. Water mobility shows a characteristic transition at about -60 degrees C, which is identified as the melting of the interfacial/hydrate water. The amount of water in the low-temperature mobile fraction is about h = 0.4 g water/g protein, which equals the hydration required for protein activity. The amount of mobile water is temperature-independent up to about -10 degrees C, with a significant increase at higher temperatures below 0 degrees C. Above 0 degrees C, the relaxation processes can be described by a single (for spin-lattice) and by a triple (for spin-spin relaxation) exponential function. The spin-spin relaxation rate component of R(2) = 10-20 s(-1) and its dynamical parameters characterize the interfacial water at ambient or physiological temperatures. When considered an independent phase, the specific heat of the hydrate water obtained by a combination of DSC and NMR data in the temperature range -43 degrees C to -28 degrees C is higher than that of pure/bulk water. This discrepancy can only be resolved by assuming that the hydrate water is in strong thermodynamic coupling with the protein matrix. The specific heat for the system composed of the protein molecule and its hydration water is 4.6 +/- 0.3 J g(-1) K(-1). Thus, in a thermodynamic sense, crystalline protein and its hydrate layer behave as a highly-interconnected single phase.


Subject(s)
Body Water/metabolism , Crystallins/metabolism , Lens, Crystalline/metabolism , Water/metabolism , Animals , Calorimetry, Differential Scanning , Chickens , Cold Temperature , Hot Temperature , Magnetic Resonance Spectroscopy , Turkeys
9.
Eur J Med Res ; 15(1): 1-12, 2010 Jan 29.
Article in English | MEDLINE | ID: mdl-20159665

ABSTRACT

This manuscript is communicated by the German AIDS Society (DAIG) (www.daignet.de). It summarizes a series of presentations and discussions during a workshop on immune activation due to HIV infection. The workshop was held on November 22nd 2008 in Hamburg, Germany. It was organized by the ICH Hamburg under the auspices of the German AIDS Society (DAIG e.V.).


Subject(s)
HIV Infections/immunology , Immune System/immunology , Immune System/virology , Germany , Humans
10.
Science ; 285(5431): 1261-5, 1999 Aug 20.
Article in English | MEDLINE | ID: mdl-10455052

ABSTRACT

The early events during infection with an immunodeficiency virus were followed by application of pathogenic simian immunodeficiency virus atraumatically to the tonsils of macaques. Analyses by virologic assays and in situ hybridization revealed that the infection started locally in the tonsils, a mucosal-associated lymphoid organ, and quickly spread to other lymphoid tissues. At day 3, there were few infected cells, but then the number increased rapidly, reaching a high plateau between days 4 and 7. The infection was not detected in the dendritic cell-rich squamous epithelium to which the virus was applied; instead, it was primarily in CD4+ tonsillar T cells, close to the specialized antigen-transporting epithelium of the tonsillar crypts. Transport of the virus and immune-activating stimuli across this epithelium would allow mucosal lymphoid tissue to function in the atraumatic transmission of immunodeficiency viruses.


Subject(s)
Lymphoid Tissue/virology , Mouth Mucosa/virology , Palatine Tonsil/virology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/physiology , Animals , CD4-Positive T-Lymphocytes/virology , Epithelium/virology , Female , In Situ Hybridization , Leukocytes, Mononuclear/virology , Lymph Nodes/virology , Macaca mulatta , Male , Simian Acquired Immunodeficiency Syndrome/transmission , Viral Load , Virus Replication
11.
Science ; 283(5403): 857-60, 1999 Feb 05.
Article in English | MEDLINE | ID: mdl-9933172

ABSTRACT

Clinical evidence suggests that cellular immunity is involved in controlling human immunodeficiency virus-1 (HIV-1) replication. An animal model of acquired immune deficiency syndrome (AIDS), the simian immunodeficiency virus (SIV)-infected rhesus monkey, was used to show that virus replication is not controlled in monkeys depleted of CD8+ lymphocytes during primary SIV infection. Eliminating CD8+ lymphocytes from monkeys during chronic SIV infection resulted in a rapid and marked increase in viremia that was again suppressed coincident with the reappearance of SIV-specific CD8+ T cells. These results confirm the importance of cell-mediated immunity in controlling HIV-1 infection and support the exploration of vaccination approaches for preventing infection that will elicit these immune responses.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/immunology , Acquired Immunodeficiency Syndrome/immunology , Acquired Immunodeficiency Syndrome/virology , Animals , Antibodies, Monoclonal/immunology , Antibodies, Viral/blood , Disease Progression , Gene Products, gag/blood , Humans , Lymphocyte Count , Lymphocyte Depletion , Macaca mulatta , Neutralization Tests , RNA, Viral/blood , Simian Immunodeficiency Virus/physiology , T-Lymphocytes, Cytotoxic/immunology , Time Factors , Viral Load , Viremia/immunology , Viremia/virology , Virus Replication
12.
Science ; 286(5443): 1353-7, 1999 Nov 12.
Article in English | MEDLINE | ID: mdl-10558989

ABSTRACT

In sexual transmission of simian immunodeficiency virus, and early and later stages of human immunodeficiency virus-type 1 (HIV-1) infection, both viruses were found to replicate predominantly in CD4(+) T cells at the portal of entry and in lymphoid tissues. Infection was propagated not only in activated and proliferating T cells but also, surprisingly, in resting T cells. The infected proliferating cells correspond to the short-lived population that produces the bulk of HIV-1. Most of the HIV-1-infected resting T cells persisted after antiretroviral therapy. Latently and chronically infected cells that may be derived from this population pose challenges to eradicating infection and developing an effective vaccine.


Subject(s)
CD4-Positive T-Lymphocytes/virology , HIV Infections/transmission , HIV-1/physiology , Lymphocyte Activation , Simian Acquired Immunodeficiency Syndrome/transmission , Simian Immunodeficiency Virus/physiology , Animals , Anti-HIV Agents/therapeutic use , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , Cell Cycle , Cervix Uteri/virology , Epithelial Cells/virology , Female , HIV Infections/drug therapy , HIV Infections/virology , Lymph Nodes/virology , Macaca mulatta , RNA, Viral/analysis , Simian Acquired Immunodeficiency Syndrome/virology , Time Factors , Virus Replication
13.
Adv Genet ; 95: 217-51, 2016.
Article in English | MEDLINE | ID: mdl-27503359

ABSTRACT

Mycobacterium marinum infection in zebrafish has become a well-established model of tuberculosis. Both embryonic and adult zebrafish infection studies have contributed to our knowledge of the development and function of tuberculous granulomas, which are typical of mycobacterial pathogenesis. In this review we discuss how transcriptome profiling studies have helped to characterize this infection process. We illustrate this using new RNA sequencing (RNA-Seq) data that reveals three main phases in the host response to M. marinum during the early stages of granuloma development in zebrafish embryos and larvae. The early phase shows induction of complement and transcription factors, followed by a relatively minor induction of pro-inflammatory cytokines within hours following phagocytosis of M. marinum. A minimal response is observed in the mid-phase, between 6 hours and 1day post infection, when the tissue dissemination of M. marinum begins. During subsequent larval development the granulomas expand and a late-phase response is apparent, which is characterized by progressively increasing induction of complement, transcription factors, pro-inflammatory cytokines, matrix metalloproteinases, and other defense and inflammation-related gene groups. This late-phase response shares common components with the strong and acute host transcriptome response that has previously been reported for Salmonella typhimurium infection in zebrafish embryos. In contrast, the early/mid-phase response to M. marinum infection, characterized by suppressed pro-inflammatory signaling, is strikingly different from the acute response to S. typhimurium infection. Furthermore, M. marinum infection shows a collective and strongly fluctuating regulation of lipoproteins, while S. typhimurium infection has pronounced effects on amino acid metabolism and glycolysis.


Subject(s)
Immunity, Innate/immunology , Transcriptome/genetics , Transcriptome/immunology , Tuberculosis/genetics , Tuberculosis/immunology , Zebrafish/genetics , Zebrafish/immunology , Animals , Disease Models, Animal , Granuloma/genetics , Granuloma/immunology , Granuloma/microbiology , Humans , Immunity, Innate/genetics , Mycobacterium Infections, Nontuberculous/genetics , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium Infections, Nontuberculous/microbiology , Tuberculosis/microbiology , Zebrafish/microbiology
14.
Curr Top Microbiol Immunol ; 276: 1-30, 2003.
Article in English | MEDLINE | ID: mdl-12797441

ABSTRACT

Dendritic cells (DCs) can influence HIV-1 and SIV pathogenesis and protective mechanisms at several levels. First, HIV-1 productively infects select populations of DCs in culture, particularly immature DCs derived from blood monocytes and skin (Langerhans cells). However, there exist only a few instances in which HIV-1- or SIV-infected DCs have been identified in vivo in tissue sections. Second, different types of DCs reliably sequester and transmit infectious HIV-1 and SIV in culture, setting up a productive infection in T cells interacting with the DCs. This stimulation of infection in T cells may explain the observation that CD4+ T lymphocytes are the principal cell type observed to be infected with HIV-1 in lymphoid tissues in vivo. DCs express a C-type lectin, DC-SIGN/CD209, that functions to bind HIV-1 (and other infectious agents) and transmit virus to T cells. When transfected into the THP-1 cell line, the cytosolic domain of DC-SIGN is needed for HIV-1 sequestration and transmission. However, DCs lacking DC-SIGN (Langerhans cells) or expressing very low levels of DC-SIGN (rhesus macaque monocyte-derived DCs) may use additional molecules to bind and transmit immunodeficiency viruses to T cells. Third, DCs are efficient antigen-presenting cells for HIV-1 and SIV antigens. Infection with several recombinant viral vectors as well as attenuated virus is followed by antigen presentation to CD4+ and CD8+ T cells. An intriguing pathway that is well developed in DCs is the exogenous pathway for nonreplicating viral antigens to be presented on class I MHC products. This should allow DCs to stimulate CD8+ T cells after uptake of antibody-coated HIV-1 and dying infected T cells. It has been proposed that DCs, in addition to expanding effector helper and killer T cells, induce tolerance through T cell deletion and suppressor T cell formation, but this must be evaluated directly. Fourth, DCs are likely to be valuable in improving vaccine design. Increasing DC uptake of a vaccine, as well as increasing their numbers and maturation, should enhance efficacy. However, DCs can also capture antigens from other cells that are initially transduced with a DNA vaccine or a recombinant viral vector. The interaction of HIV-1 and SIV with DCs is therefore intricate but pertinent to understanding how these viruses disrupt immune function and elicit immune responses.


Subject(s)
Dendritic Cells/virology , HIV-1/physiology , T-Lymphocytes/virology , Animals , Antigen Presentation/immunology , Antigens, Viral/immunology , Biological Transport , Dendritic Cells/immunology , HIV Infections/immunology , HIV Infections/pathology , HIV Infections/virology , Humans , Monocytes/immunology , Simian Immunodeficiency Virus/physiology , T-Lymphocytes/immunology , Vaccination
15.
Mol Immunol ; 38(2-3): 241-7, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11532285

ABSTRACT

Since the first contact with the host, human immunodeficiency virus (HIV) exploits the complement system to reach maximal spread of infection. HIV has adapted many strategies to avoid complement-mediated lysis and uses the opsonization with complement fragments for attachment to complement receptors (CR). From the pathogen's perspective, binding to CR-expressing cells is remarkably beneficial, bringing together virus and activated target cells that are highly susceptible to infection. Moreover, complement-mediated trapping on CR+ cells permits HIV to infect surrounding cells even in the presence of an excess of neutralizing antibodies. Thus, complement activation initiates the assumption of power over the host's immune system by HIV and thus augments viral spread and replication throughout the body. On the other hand, natural hosts of primate lentiviruses, such as sooty mangabeys, African green monkeys and chimpanzees, are generally considered to be resistant to the development of AIDS, despite persistent viral replication. This review focuses on the possible link between the resistance to disease and species-specific diversity in function of human and monkey complement system.


Subject(s)
Complement System Proteins , HIV Infections/immunology , Lentiviruses, Primate/pathogenicity , Simian Acquired Immunodeficiency Syndrome/immunology , Animals , HIV Infections/etiology , Haplorhini , Humans , Immunity, Innate , Simian Acquired Immunodeficiency Syndrome/etiology , Species Specificity
16.
Sci Rep ; 5: 7584, 2015 Jan 12.
Article in English | MEDLINE | ID: mdl-25579608

ABSTRACT

We investigated nonlinear photoemission from plasmonic films with femtosecond, mid-infrared pulses at 3.1 µm wavelength. Transition between regimes of multi-photon-induced and tunneling emission is demonstrated at an unprecedentedly low intensity of <1 GW/cm(2). Thereby, strong-field nanophysics can be accessed at extremely low intensities by exploiting nanoscale plasmonic field confinement, enhancement and ponderomotive wavelength scaling at the same time. Results agree well with quantum mechanical modelling. Our scheme demonstrates an alternative paradigm and regime in strong-field physics.

17.
AIDS ; 2(4): 299-309, 1988 Aug.
Article in English | MEDLINE | ID: mdl-3140835

ABSTRACT

To investigate the role of the lymphatic vessels and the sinus systems of the lymph node in the spread of HIV-1, we evaluated 15 lymph nodes from patients with persistent generalized lymphadenopathy (PGL). Fifteen lymph nodes taken from patients with follicular hyperplasia not related to HIV-1 infection served as controls. Immunohistochemical and in situ hybridization techniques revealed infected cells within the sinuses and the efferent lymphatics of the PGL lymph nodes. In contrast, infected cells could not be detected within the walls of the high endothelial venules nor in the areas immediately adjacent. The parenchymal side of the marginal sinus was lined by a discontinuous endothelium. Macrophages and lymphocytes were located within the gaps of this endothelium. More importantly, when the enlarged follicle extended as far as the wall of the marginal sinus, the processes of follicular dendritic cells could be seen extending through the gaps into the lumen of the sinus. This suggests that these cells could transport antigens (including HIV-1) from the sinuses directly to the germinal centers. In addition, HIV-1 particles within cytoplasmic vacuoles were seen in infected macrophages located in the submarginal zone. Positive cells were also found in the extrafollicular lymphoid parenchyma, especially in the area between the marginal sinus and the follicles. The observed distribution of the virus-positive cells within the PGL lymph nodes strongly implicates the lymphatic vessels in the spread of HIV-1 infection.


Subject(s)
Acquired Immunodeficiency Syndrome/physiopathology , HIV-1/immunology , Lymphatic Diseases/physiopathology , Lymphatic System/physiology , Acquired Immunodeficiency Syndrome/pathology , Antibodies, Monoclonal , Cell Movement , Humans , Immunoenzyme Techniques , Lymph Nodes/physiology , Lymph Nodes/ultrastructure , Lymphatic Diseases/pathology , Lymphatic System/ultrastructure , Nucleic Acid Hybridization
18.
AIDS ; 11(7): 849-57, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9189209

ABSTRACT

OBJECTIVE: CD4+ T cells are the main target for HIV. However, the highest HIV antigen concentration in infected subjects accumulates on the cell surface of follicular dendritic cells in the germinal centres of the lymphoid tissue. Germinal centres contain a T-helper cell subset which expresses CD57 molecules. Here we analysed virus replication and viral load in CD57+CD4+ germinal centre T cells and in the CD4+ T cells found mostly outside germinal centres (CD57-CD4+). METHODS: Peripheral blood mononuclear cells and lymph-node cells were prepared, stained for CD4 and CD57 and purified by FACS. Defined cell numbers of CD4+CD57+ cells and CD4+CD57- cells were sorted directly into polymerase chain reaction (PCR) tubes by FACS, equipped with an automated cell deposition unit and analysed by PCR to detect proviral DNA. Based on Poisson distribution, the expected level of infection was calculated. Viral replication was determined by amplifying double-spliced, single-spliced, and full-length transcripts of HIV using serially diluted cDNA of the FACS-sorted cells. RESULTS: An up to 10-fold higher frequency of infected cells was found in the CD57+CD4+ germinal centre T cells compared with CD57-CD4+ T cells. Furthermore, active viral replication was detected almost exclusively in the CD57+CD4+ T cells. CONCLUSIONS: The CD57+CD4+ germinal centre T cells are one of the sites of HIV infection and replication that may play a pivotal role in the pathogenesis of HIV infection.


Subject(s)
CD4-Positive T-Lymphocytes/virology , Germinal Center/virology , HIV Infections/virology , HIV-1/physiology , Virus Replication , Base Sequence , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , CD57 Antigens/immunology , DNA, Viral , Germinal Center/cytology , Germinal Center/immunology , HIV Infections/immunology , HIV Infections/pathology , HIV-1/genetics , HIV-1/isolation & purification , Humans , Male , Molecular Sequence Data , Viral Load
19.
AIDS ; 5(3): 255-62, 1991 Mar.
Article in English | MEDLINE | ID: mdl-1711861

ABSTRACT

Knowledge about B-cell dysfunction and HIV-specific antibody production is necessary for the understanding of both HIV-1-related immunopathology and the (vaccine-induced) humoral immunity involved in protection against AIDS. This paper describes the application of recently developed methods to detect epitope specificity of B cells in lymph-node biopsies with antigen-enzyme conjugates. Cryosections of five lymph-node biopsies from HIV-1-infected individuals and four control tissues were stained with a panel of HIV-1 antigen-enzyme conjugates: recombinant HIV-1 proteins (gp 160, gp 120 and p24), labelled with peroxidase, and synthetic peptides representing neutralizing epitopes from gp120 and gp41, labelled with alkaline phosphatase. Antibody-forming cells (AFCs) were detected in all the HIV-1-infected biopsies with gp160, gp120 and/or p24, in numbers up to 350 per section. AFCs producing specific antibodies against peptide 101 (SP 101), representing the neutralizing epitope 586-608 of gp41, were detected in one patient. These techniques allow correlation of in vivo function of B cells with lymph-node pathology, clinical stage of the disease and serological data. Their potential for the elucidation of HIV-related immunopathogenesis and the development of vaccines is discussed.


Subject(s)
B-Lymphocytes/immunology , Epitopes/immunology , HIV Antigens/immunology , HIV Infections/immunology , HIV-1/immunology , Amino Acid Sequence , Biopsy , HIV Antibodies/biosynthesis , HIV Antibodies/immunology , HIV Infections/pathology , Horseradish Peroxidase , Humans , Lymph Nodes/pathology , Molecular Sequence Data , Peptide Fragments/chemical synthesis , Peptide Fragments/immunology , Recombinant Proteins/immunology , Retroviridae Proteins/immunology
20.
AIDS ; 1(2): 95-104, 1987 Jul.
Article in English | MEDLINE | ID: mdl-3130085

ABSTRACT

Recently there has been much interest in using immunohistology with monoclonal antibodies (MABs) against different cells of the immune system in lymph nodes (LNs) of patients with HIV infection. The panel of these MABs is becoming increasingly extensive. In this study we report on our finding that by using a limited number of properly chosen MABs, diagnostically and prognostically relevant parameters can be acquired. One hundred and twenty-one LN biopsy specimens from patients with HIV infection were reviewed and classified according to our expanded working classification and a fifth main type of LN lesion, the small lymphocyte follicular type, was added to our earlier classification. We propose that this new type represents a transitional form between the mixed follicular type and the follicular depleted type. In the follicular type of LN lesion there is no marked change in the number of CD4 cells within the follicles and in the extrafollicular parenchyma. The reaction against the major core proteins of HIV is always positive and the number of proliferating cells is very high. The positivity is weaker in the earlier cases and stronger in the older ones. The follicular dendritic cell (FDC) network shows degenerative changes. In the hypervascular follicular type the reaction pattern with these selected MABs is very similar to the one in the follicular type. In the mixed type there are hyperplastic follicles and regressively transformed follicles in the same node. The hyperplastic follicles show a pattern similar to those in the follicular type. However, the reaction with MABs against core proteins of HIV is often markedly stronger. The number of proliferating cells is decreased markedly. Some follicles show extensive FDC network destruction. CD4 cells within the follicles and in the extrafollicular parenchyma are decreased. The regressively transformed follicles contain very few proliferating cells and the reaction with MABs against core proteins is variable, being strong in some follicles and weak in others. The small lymphocyte type contains follicles consisting mainly of small lymphocytes. These lymphocytes are of the same phenotype as those in the primary follicles. In contrast to these, however, the numbers of CD4 and Leu 7+ cells are much decreased. The reaction with MABs to core proteins is weak and limited to the germinal centres (GCs). The number of proliferating cells is strongly diminished. The FDC network, however, is well developed in most follicles. In the follicular depleted LNs there are no follicles; however, in some LNs remnants of FDC can be seen.


Subject(s)
Acquired Immunodeficiency Syndrome/pathology , Antibodies, Monoclonal , HIV/immunology , Lymph Nodes/pathology , AIDS-Related Complex/immunology , AIDS-Related Complex/pathology , Acquired Immunodeficiency Syndrome/immunology , Adolescent , Adult , Antibodies, Monoclonal/immunology , Antibodies, Viral/immunology , Antigens, Viral/isolation & purification , Female , HIV Antibodies , HIV Antigens , Humans , Immunohistochemistry , Lymph Nodes/immunology , Male , Middle Aged , Viral Core Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL